Proactive Investors - Run By Investors For Investors

Instem performing well; SEND platform stars

The company has developed software used by the life sciences industry to collate and transmit data
Instem performing well; SEND platform stars
SEND stands for Standard for the Exchange of Nonclinical Data and is a protocol set up by the US Food and Drug Administration

Instem Plc (LON:INS), the developer of software used by the life sciences industry to collate and transmit data, said first-half trading was in line with market expectations.

The highlight was the performance of its SEND platform, with the value of contracts won thus far in 2018 exceeding the total for all of last year.

In all, it had 103 orders in the first six months from 50 different clients.

Instem said the contracted value of the SEND-related new business was up 190% year-on-year, while the pipeline continues to grow, driven by the US Food & Drug Administration’s investigational new drug rules.

SEND stands for Standard for the Exchange of Nonclinical Data and is a protocol set up by the US Food and Drug Administration. It ensures that companies present data in a consistent format.

Sending the right message

It said a further shift towards providing its software as a service (rather than making one-off sales), combined with “increasingly material recurring outsourced services revenue”, will see a continued improvement of earnings visibility.

Both its Provantis and Samarind products are accessible via the cloud.

Financially, Instem has a solid base with net cash of £3.7mln at June 30.

"The financial year has started well and we are confident further new business, the delivery of recent contract wins and strong operational management will ensure we meet our expectations for the full year," said chief executive Phil Reason.

Shares more than double in value

The shares, which have more than doubled in value in the year to date, rise 7% in morning trade to change hands for 315p. This values the business at £50mln.

In a note to clients, Progressive Equity said: “In our view, the overall tone of the update is optimistic and the outlook statement positive.”

View full INS profile View Profile

Instem PLC Timeline

Related Articles

1534442111_IoT.jpg
August 16 2018
In March, it formed a joint venture with New Hope Data Technology Co Ltd, which is affiliated to conglomerate New Hope Group
Virtual Reality headset
May 02 2018
The integration of the group's Apollo 11 experience into the Oculus Go launch package has seen its share price rocket up over 40%
Apps on a smartphone
December 17 2018
“While this year our focus has very much been about developing our product, in the coming year the primary objective will be to increase revenues and margins,” chief executive Philip Marcella said

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use